Add BrightSurf on Google Email

CCDC - Cambridge Crystallographic Data Centre


Synthetic routes to pharmaceuticals greatly expanded leading to new and more effective treatments

A search of the Cambridge Structural Database found nearly 1,800 conglomerate crystal structures with spontaneous enriched chirality, augmenting synthetic building blocks for medicinal chemists. This discovery introduces a new pool of chiral molecules outside of natural sources, potentially leading to more effective treatments.

SourceCCDC - Cambridge Crystallographic Data Centre·JournalJACS Au·TypeData/statistical analysis·DateOct 6, 2022

CSD-Materials suite provides a cohesive analysis of solid form properties for early-phase drug discovery

The CSD-Materials suite provides a comprehensive analysis of solid form properties, helping researchers explore intra- and intermolecular interactions. The suite's components, including Hydrogen Bond Propensity, Full Interaction Maps, and Aromatics Analyser, aid in identifying potential co-former or solvent interactions for new APIs.

SourceCCDC - Cambridge Crystallographic Data Centre·JournalCrystal Growth & Design·DateMar 15, 2022

Is your ML training set biased? How to develop new drugs based on merged datasets

Researchers at GlaxoSmithKline and CCDC combined proprietary and published datasets to train machine learning models for predicting stable polymorphs in new drug candidates. The approach leverages the large volume and variety of data in the Cambridge Structural Database, resulting in more confident predictions and improved model accuracy.